PetVivo Holdings Retained Earnings (Accumulated Deficit) 2011-2024 | PETV

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

PetVivo Holdings retained earnings (accumulated deficit) from 2011 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

PetVivo Holdings Retained Earnings (Accumulated Deficit) 2011-2024 | PETV

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Related Stocks
Company Name	Market Cap
Thermo Fisher Scientific (TMO)	$228.7B
Intuitive Surgical (ISRG)	$171.3B
Alcon (ALC)	$48B
IQVIA Holdings (IQV)	$41.9B
Edwards Lifesciences (EW)	$39.5B
IDEXX Laboratories (IDXX)	$39.3B
DexCom (DXCM)	$27.3B
STERIS (STE)	$22.8B
SONOVA HOLDING (SONVY)	$21.9B
Waters (WAT)	$20.9B
Hologic (HOLX)	$18.6B
Sysmex ADR (SSMXY)	$12.5B
Fresenius Medical Care AG KGaA (FMS)	$12.1B
Teleflex (TFX)	$11.3B
Globus Medical (GMED)	$9.6B
Penumbra (PEN)	$7.6B
Masimo (MASI)	$7.4B
Glaukos (GKOS)	$7.2B
TransMedics (TMDX)	$4.6B
Integer Holdings (ITGR)	$4.3B
PROCEPT BioRobotics (PRCT)	$3.8B
LivaNova (LIVN)	$2.9B
Tandem Diabetes Care (TNDM)	$2.7B
Nihon Kohden (NHNKY)	$2.6B
Elekta AB (EKTAY)	$2.6B
Veracyte (VCYT)	$2.5B
Inari Medical (NARI)	$2.4B
RxSight (RXST)	$1.8B
Integra LifeSciences Holdings (IART)	$1.3B
Artivion (AORT)	$1.1B